The bond market has entered a financial twilight zone, and at this point, there doesn't seem to be a smooth way out.Market Insiderread more
Trump said he has "been thinking about payroll taxes for a long time" — and he cautioned that "whether or not we do something now, it's not being done because of recession."Politicsread more
Market bull Jeff Saut told CNBC on Tuesday that the lows are in and the market is headed "much higher."Marketsread more
Urban Outfitters reported earnings and same-store sales for the second quarter that beat analyst expectations, while revenue fell short.Retailread more
President Donald Trump believes he has quite the bargaining chip with the European Union.Marketsread more
Some Apple employees have become disillusioned with the group's culture, where some have thrived while others feel sidelined.Technologyread more
President Donald Trump renewed calls Tuesday to readmit Russia to the G7 ahead of the group's summit in Biarritz, France, this weekend.Politicsread more
Biden has shown staying power at the top of a jammed Democratic field even as polling numbers for Sanders, Warren and Harris wax and wane.2020 Electionsread more
The FDIC on Tuesday votes to approve a five-agency revision of the post-crisis regulation known as the Volcker Rule.Financeread more
The yield curve is the only economic indicator pointing to a recession, according to Credit Suisse.Marketsread more
Amid fears of a recession, Domino's Pizza CEO Ritch Allison said Tuesday that the U.S. consumer is still strong.Restaurantsread more
Seattle's prestigious Institute for Systems Biology has long been a draw for star experimental scientists. But it's now in a battle for talent with some deep-pocketed competitors: Amazon and Google.
Out of a group of a dozen researchers, four have recently left for Amazon, Google and Microsoft, said Nathan Price, associate director of ISB, which is now owned by Providence Health & Services, a non-profit network of hospitals.
Rather than fighting to hang onto the institute's standout biologists and bioinformaticists, Price has figured out a way to embrace the trend.
"We're asking talented researchers to come spend a few years with us, and develop something cool before they get recruited out," he told CNBC.
Prized academics are in high demand by technology companies, which are racing to bring cloud computing and machine learning to the $3 trillion health care market. ISB, for instance, uses both Amazon Web Services and Google's cloud technology on various projects.
As tech companies vie for contracts with large health systems to manage a growing volume of their most sensitive data, they need employees on board who understand specific topics like protein networks and gene networks, said Price.
At ISB, which was co-founded by genetics pioneer Leroy "Lee" Hood, researchers bolster their scientific knowledge by taking engineering courses from services like education site Coursera, said Price.
In the future, Price said that academic institutions will need to figure out a way to better compete with the industry. Currently, tech firms can pay so much more that he's losing talent even when scientists have little clarity about what they'll be doing. Alphabet's life sciences arm Verily hired one of his data scientists without providing specifics on the project, Price said.
"These people are really important to the future of what we want to do," he said. "In academia, we need to close the gap more than we have been."